Diabetes Metab J.
2024 Nov;48(6):1176-1178. 10.4093/dmj.2024.0551.
Targeting Cardiac Fibrosis in Diabetic Heart Failure: The Role of the EZH2, AMPK, and PPAR-γ Pathways (Diabetes Metab J 2024;48:716-29)
- Affiliations
-
- 1Department of Internal Medicine, Armed Forces Yangju Hospital, Yangju, Korea
- 2Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
- KMID: 2561801
- DOI: http://doi.org/10.4093/dmj.2024.0551
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Diabetes Promotes Myocardial Fibrosis via AMPK/EZH2/PPAR-γ Signaling Pathway (Diabetes Metab J 2024;48:716-29)
- Diabetes Promotes Myocardial Fibrosis via AMPK/EZH2/PPAR-γ Signaling Pathway
- Heart Failure: Complications of Type 2 Diabetes
- Role of Peroxisome Proliferator-Activated Receptor alpha in Diabetic Nephropathy
- Diabetes and Heart Failure
